DL-Phenylalanine (DLPA)
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
DL-Phenylalanine (DLPA). Racemic phenylalanine for pain and mood.
How it works. D-isomer inhibits enkephalinase; L-isomer is catecholamine precursor.
What the research supports. 1 graded claims. Strongest: May reduce chronic pain (moderate).
How much to take. Typical dose: 500–1500 mg.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with A high-quality multivitamin, Omega-3 (EPA/DHA).
Common forms. Available as Free-form crystalline powder, Capsules or tablets, Pre-mixed recovery or hydration beverages, Time-release formulations.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried DL-Phenylalanine (DLPA). Anecdotes are not medical advice.
DL-Phenylalanine (DLPA). Racemic phenylalanine for pain and mood.
What it is
Racemic phenylalanine for pain and mood.
Food sources
Goals
How it works
D-isomer inhibits enkephalinase; L-isomer is catecholamine precursor.
Pathways
- D-isomer inhibits enkephalinase
- L-isomer is catecholamine precursor
Effects
- +May reduce chronic pain supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Headache
- Anxiety
Medication interactions
Always disclose DL-Phenylalanine (DLPA) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- A high-quality multivitaminCovers micronutrient cofactors that support most supplement pathways.
- Omega-3 (EPA/DHA)Foundational anti-inflammatory support that complements most regimens.
Common forms
- Free-form crystalline powder
- Capsules or tablets
- Pre-mixed recovery or hydration beverages
- Time-release formulations
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "May reduce chronic pain". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…